HEIDELBERG IMMUNOTHERAPEUTICS GMBH has a total of 12 patent applications. Its first patent ever was published in 2010. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets pharmaceuticals and biotechnology are AMPHIVENA THERAPEUTICS INC, BIOCLIN THERAPEUTICS INC and EXIRIS S R L.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | United States | 2 | |
#3 | Australia | 1 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | Republic of Korea | 1 | |
#7 | Russian Federation | 1 | |
#8 | Singapore | 1 | |
#9 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Arndt Michaela | 9 |
#2 | Krauss Jürgen | 6 |
#3 | Krawczyk Adalbert | 3 |
#4 | Roggendorf Michael | 3 |
#5 | Schneweis Karl Eduard | 3 |
#6 | Jäger Dirk | 3 |
#7 | Exner Evelyn | 3 |
#8 | Eis-Hübinger Anna-Maria | 3 |
#9 | Dirk Jäger | 2 |
#10 | Michaela Arndt | 2 |
Publication | Filing date | Title |
---|---|---|
SG11201610320RA | Topical application for an anti-hsv antibody |